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ABSTRACT
Oxidative stress may play a key role in Alzheimer’s disease (AD) neuropathology. Pomegranates (石榴 Shí Liú) contain very 
high levels of antioxidant polyphenolic substances, as compared to other fruits and vegetables. Polyphenols have been shown 
to be neuroprotective in different model systems. Here, the effects of the antioxidant‑rich pomegranate fruit grown in Oman on 
brain oxidative stress status were tested in the AD transgenic mouse. The 4‑month‑old mice with double Swedish APP mutation 
(APPsw/Tg2576) were purchased from Taconic Farm, NY, USA. Four‑month‑old Tg2576 mice were fed with 4% pomegranate or 
control diet for 15 months and then assessed for the influence of diet on oxidative stress. Significant increase in oxidative stress 
was found in terms of enhanced levels of lipid peroxidation (LPO) and protein carbonyls. Concomitantly, decrease in the activities 
of antioxidant enzymes was observed in Tg2576 mice treated with control diet. Supplementation with 4% pomegranate attenuated 
oxidative damage, as evidenced by decreased LPO and protein carbonyl levels and restoration in the activities of the antioxidant 
enzymes [superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione (GSH), and Glutathione S transferase 
(GST)]. The activities of membrane‑bound enzymes [Na+ K+‑ATPase and acetylcholinesterase (AChE)] were altered in the brain 
regions of Tg2576 mouse treated with control diet, and 4% pomegranate supplementation was able to restore the activities of enzymes 
to comparable values observed in controls. The results suggest that the therapeutic potential of 4% pomegranate in the treatment of 
AD might be associated with counteracting the oxidative stress by the presence of active phytochemicals in it.
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INTRODUCTION
Alzheimer’s disease (AD) is a progressive neurodegenerative 
disorder and the most prevalent form of dementia characterized 
by a progressive decline in memory, behavior, and cognitive 
functions in the elderly population.[1] It affects millions of people 
and has become a major medical and social burden in developed 
and developing countries.[2] The disease has been the sixth lead‑
This is an open access article under the CC BY-NC-ND license.
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ing cause of death across all ages and the fifth leading cause of 
death in those aged 65 and above. The neuropathology of AD is 
characterized at first by the deposition of senile plaques mainly 
composed of amyloid beta protein (Aβ) and neurofibrillary 
tangles containing hyperphosphorylated tau protein in the brain 
and later by the loss of neurons and their processes.[3,4] Cogni‑
tive impairment appears to be most closely correlated in time 
with the loss of neurons and neuronal processes.[5] At present, 
the etiology of AD is still not well understood. Accumulation 
of Aβ peptide causes an increase in intracellular reactive free 
radicals and reactive oxygen species (ROS). The generation of 
free radicals (ROS) due to the Aβ peptide can induce functional 
and structural damage to cell membranes through lipid per‑
oxidation (LPO) and protein carbonyl formation which may be 
involved in the pathogenesis of AD.[6] These abnormal events in 
cells lead to oxidative neuronal cell death and cognitive decline 
in patients with AD.[7] However, the relationship between plaque 
and tangle deposition and the neuronal degeneration that follows 
it is not clearly understood.
More recently, the interest in the role of dietary antioxidants 
in human health has prompted research in the field of AD. Fruits 
are good sources of these bioactives, and there are a number of 
commercial polyphenol‑rich beverages which base their market‑
ing strategies on antioxidant potency.   Naturally occurring com‑
pounds from plants have been shown to have therapeutic potential 
f or AD.[8‑10] Curcumin and Ginkgo biloba extract are such natural 
compounds that have been shown to be protective against the 
progression of AD pathology in AD murine models.[11,12] Medi‑
terranean and Middle East countries are the main regions where 
pomegranate (石榴 Shí Liú) is cultivated and produced.[13,14] 
Pomegranates (Punica granatum Linn.) contain very high levels 
of polyphenols, as compared to other fruits and vegetables. They 
have been extensively used in Unani, Ayurvedic, and Chinese 
systems of medicine.[15] Different parts of the fruit have been 
successfully evaluated for various diseases, including peptic 
ulcer, hepatic damage, and snakebite. The ripe fruit is a tonic, 
astringent to the bowels, aphrodisiac, and alleged panacea for a 
myriad of conditions, including biliousness, fever, heart diseases, 
sore throat, and stomatitis. The rind of the fruit is antihelminthic 
and useful in diarrhea, dysentery, and ulcer (Ayurveda).[16] Re‑
cently, we have reported that the four different pomegranate 
varieties grown in Oman offer protection to Parkinson’s disease 
like neurotoxicity in human primary neurons.[17] Dietary supple‑
mentation of pregnant mice with pomegranate juice was shown 
to protect against neurodegeneration in neonatal mice subjected 
to hypoxic–ischemic brain injury.[18] A recent study suggested that 
3 months of supplementation with pomegranate may attenuate 
AD progression by offering the brain anti‑inflammatory effects 
in amyloid precursor protein/presenilin 1 (APP/PS1) transgenic 
mice.[19] But till now, there are no studies conducted to find out 
the effect of long‑term dietary supplementation of pomegranate 
on oxidative stress status in APPSw/Tg2576 transgenic mouse 
model. To fill the information gap, we designed this study to 
find out whether long‑term dietary supplementation (15 months) 
with pomegranate would influence AD‑like oxidative stress in an 
APPsw/Tg2576 mouse model of AD.
MATERIALS AND METHODS
Collection and preparation
Fresh pomegranate (石榴 Shí Liú) “Helow” (literally, sweet) 
variety of Oman fruits were purchased from a local farm in Al‑Jabal 
Al‑Akhdar, Oman. The fruits were transported to our laboratory 
in an electric cooler box maintained at 9°C. Then the edible parts 
were separated and freeze dried at −40°C for 5 days. The samples 
were then grinded into fine powder by using a KMF grinder (KIKA 
Werke, Wilmington, Delaware USA) at 6000 rpm. Powders were 
kept in air‑tight plastic containers and stored at −40°C until they 
were sent for the diet preparation. Before sending, we analyzed 
the samples for the qualitative presence of polyphenols. Phyto‑
chemicals such as anthocycanin, hydroxycinnamic acid deriva‑
tives (e.g. caffeic acid, etc.), hydrolyzable tannins (e.g. ellagic 
acid, quercetin‑3‑O‑glucoside, punicalin, etc.), hydroxybenzoic 
acids (gallic acid, protocatechuic acid, etc.), hydroxycyclohexane 
carboxylic acids (quinic acid), and hydroxyphenyls (kaempferol, 
catechin, etc.) have been reported to be present in pomegranate. 
This was confirmed by qualitative analysis by high performance 
liquid chromatography (HPLC; data not included).
Diet preparation for the animals
The ground pomegranate samples were sent to USA to prepare 
the diet for the mice.   Based on the our primary dose‑dependent 
study (2, 4, 6, 8 and 10% on the amyloid beta 1‑42 induced AD 
like status in mice) results, we have chosen the 4% (data not 
shown). The diet was prepared by mixing the pomegranate (4%) 
with regular diet as per National Institute Health, USA protocol 
by Research Diet, Inc, NJ, New Brunswick USA. The constituents 
of the diet are given in  Table 1.
Animals and treatment
Twelve transgenic females (APPsw/Tg2576) and six wild 
control (non‑transgenic) mice (Taconic Farm, Hudson St, Manhat‑
tan NY, USA) were used. Animals were quarantined for 7 days 
after shipping and individually housed in plastic cages in an ani‑
mal room which was maintained at a temperature of 22 ± 2°C, a 
relative humidity of 50 ± 10%, and a 12‑h light/dark automatic 
light cycle (0800‑2000 h). Tap water was offered ad libitum 
throughout the study. The study was approved by the Animal 
Care and Use Committee of the Sultan Qaboos University, Oman 
(SQU/AEC/2010‑11/3).
All these animals were free from pathogens and viruses. 
Experimental period commenced from the age of 4 months. The 
animals were divided into three groups as follows: Group 1: Wild 
type (non‑transgenic) control of the APPsw mice fed with regular 
diet; Group 2: AD transgenic mice also fed with regular diet; and 
Group 3: AD mice fed with 4% pomegranate fruit diet. Dose of 
pomegranate was designed based on the preliminary study done 
with different percentages of fruits and 4% showed better effects. 
These experimental and control mice were examined at the age 
of 15 months, and  oxidative stress, antioxidants and membrane 
bound enzymes were investigated. All animal experiments in the 
present study were conducted in compliance with the Animal 
Care and Use Committee of the Sultan Qaboos University, Oman.
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Tissue sample collection
Following the behavioral assessments, the animals were 
decapitated with the head transferred onto dry ice, followed by 
rapid dissection of the hippocampus and the cerebral cortex, and 
homogenized in 9 volumes (1:9 w/v) of cold saline for prepara‑
tion of a 10% cerebral homogenate in an ice bath, and centrifuged 
for supernatant collection. Whole brains were rapidly removed 
simultaneously and chilled in an ice‑cold saline solution. The 
tissue samples were stored at −80°C until assay.
Assay of oxidative parameters in the brain
The hippocampus and the cerebral cortex were obtained for 
measurements of oxidative parameters.
Superoxide dismutase activity
Measurements of the superoxide dismutase (SOD) activity 
were performed as described by Sun et al.[20] Estimation was based 
on the generation of superoxide radicals produced by xanthine 
and xanthine oxidase, both of which react with nitroblue tetrazo‑
lium (NTB) to form formazan dye, followed by measurement of 
SOD activity at 550 nm by the degree of inhibition of this reaction. 
One unit of enzyme was defined as the amount of enzyme required 
at the inhibition rate of 50%. The activity of SOD was expressed 
as units/mg protein.
Determination of catalase
Catalase (CAT) activity was measured according to the method 
of Aebi.[21] Briefly, 0.1 ml of supernatant was added to a cuvette 
containing 1.9 ml of 50 mmol/L phosphate buffer (pH 7.0). The 
reaction was started with the addition of 1 ml of freshly prepared 
30 mmol/L H2O2. The variations of decomposition rate of H2O2 
were determined by spectrophotometry at 240 nm. The activity 
of catalase was expressed as units/mg protein.
Determination of glutathione
Glutathione (GSH) concentration was determined by the 
procedure of Elmann.[22] Briefly, 0.5 ml homogenate was mixed 
with 1.5 ml 0.15 M KCl and 3 ml deproteinized solution. Each 
sample was centrifuged at 3000 rpm for 10 min and the resultant 
supernatant was obtained, followed by the addition of 2 ml phos‑
phate solution and 0.5 ml 5,5’‑Dithiobis‑2‑Nitrobenzoic Acid 
(DTNB) into 0.5 ml supernatant, with the absorbance read at 
412 nm and compared with glutathione standards.
Determination of glutathione peroxidase
Hippocampal and cerebrocortical glutathione peroxidase (GPx) 
activity was determined based on the protocol developed by 
Wendel[23] by indirectly  measuring the consumption of reduced 
nicotinamide adenine dinucleotide phosphate (NADPH) at 340 nm. 
The GPx uses GSH to reduce the tert‑butyl hydroperoxide, pro‑
ducing glutathione disulfide (GSSG), which is readily reduced to 
GSH by glutathione reductase (GR) using NADPH as a reducing 
equivalent donor. SOD activity was assayed spectrophotometri‑
cally as described previously.[24] This method is based on the capac‑
ity of SOD to inhibit autoxidation of adrenaline to adrenochrome. 
The color reaction was measured at 480 nm. One unit of enzyme 
was defined as the amount of enzyme required to inhibit the rate 
of epinephrine autoxidation by 50%. The enzymatic activity was 
expressed as units (U) per milligram protein.
Determination of GR
Hippocampal and cerebrocortical GR activity was determined 
based on the protocol developed by Carlberg and Mannervik.[25] 
Briefly, GR reduces glutathione disulfide (GSSG) to GSH at the ex‑
pense of NADPH, whose disappearance was followed at 340 nm.
Determination of malondialdehyde
Malondialdehye (MDA) was measured by the method previ‑
ously described.[26] The reagents acetic acid 1.5 ml (20%) pH 3.5, 
1.5 ml thiobarbituric acid (0.8%), and 0.2 ml sodium lauryl sul‑
fate (8.1%) were added to 0.1 ml supernatant samples and heated at 
95°C for 60 min. The mixture was cooled with tap water, followed 
by centrifugation at 4000 rpm for 10 min, separation of the organic 
layer, and absorbance measurement at 532 nm by microplate 
spectrophotometry. Protein estimation was conducted according to 
Lowry’s method and the data were expressed as nmol/mg protein.
Measurement of the protein carbonyl content
The total protein carbonyl content was determined by a previ‑
ously described method for brain tissue.[27] Briefly, 1 ml aliquots of 
the homogenates containing 759‑800 mg protein/ml in each sample 
were mixed with 0.2 ml of 2,4‑dinitrophenylhydrazine (DNPH, 
10 mM) or 0.2 ml HCl (2 M). After incubation at room tempera‑
ture for 1 h in a dark room, 0.6 ml of denaturing buffer [150 mM 
sodium phosphate buffer, pH 6.8, containing 3% sodium dodecyl 
Table 1. Consituents of rodent diet with 60 kcal% fat and 4% 
pomegranate (prepared by Research Diet, Inc, USA)
Product D11111503, g% D11111503, kcal%
Protein 25 20
Carbohydrate 25 20
Fat 33 60
Total 100
kcal/g 5.0
Ingredient g kcal
Casein 200 800
l‑Cystine 3 12
Corn starch 0 0
Maltodextrin 10 125 500
Sucrose 68.8 275
Cellulose, BW 200 50 0
Soybean oil 25 225
Lard 245 2205
Mineral mix, S10026 10 0
Dicalcium phosphate 13 0
Calcium carbonate 5.5 0
Potassium citrate, 1 H2O 16.5 0
Vitamin mix, V1001 10 40
Choline bitartrate 2 0
FD and C yellow dye #5 0.025 0
FD and C red dye #40 0.025 0
FD and C blue dye #1 0 0
Pomegranate extract 32.25 4057
Total 806.1
Pomegranate extract, % 4.00
FD: Food coloring additive
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sulfate (SDS)], 1.8 ml of heptane (99.5%), and 1.8 ml of etha‑
nol (99.8%) were added sequentially and mixed by vortex agitation 
for 40 s; the mixture was then centrifuged for 15 min. Next, the 
protein that was isolated from the interface was washed two times 
with 1 ml of ethyl acetate/ethanol 1:1 (v/v) and suspended in 1 ml 
of denaturing buffer. Each DNPH sample was read at 370 nm in a 
Hitachi U‑2001 spectrophotometer against the corresponding HCl 
sample (blank); the level of total carbonylation was calculated 
using a  molar extinction coefficient of 22,000 M1 cm1.
Assay of acetylcholinesterase activity
The acetylcholinesterase (AChE) activity in the hippocampus 
and the cerebral cortex was determined according to the method 
of Ellman.[28] 0.4‑ml aliquots of homogenates were added to a 
cuvette containing 2.6 ml of phosphate buffer (pH 8.0, 0.1 M). 
Then, 100 μ1 of DTNB was added to the photocell. The absor‑
bance was measured at 412 nm. When the reading had stopped 
increasing, the photometer slit was opened to set the absorbance 
to zero. Then, 20 μl of the substrate was added. Changes in ab‑
sorbance were recorded and calculated as changes in absorbance 
per minute.
Spectrophotometric analysis of Na+ K+‑ATPase activity
The reaction mixture for the Na+ K+‑ATPase assay contained 
5 mM MgCl2, 80 mM NaCl, 20 mM KCl, 40 mM Tris–HCl buf‑
fer, pH 7.4, and purified synaptic membranes (approximately 
3 μg of protein) in a final volume of 200 μl. The enzymatic assay 
was performed at 37°C for 5 min and started by the addition of 
ATP (disodium salt, vanadium free) to a final concentration of 3 
mM. The reaction was stopped by the addition of 200 μl of 10% 
trichloroacetic acid.   Ouabain‑insensitive Mg2+‑ATPase was 
assayed under the same conditions with the addition of 1 mM 
ouabain. Na+ K+‑ATPase activity was calculated by determining 
the difference between the two assays and the inorganic phos‑
phate (Pi) released was measured. Enzyme‑specific activities were 
calculated as  nmol of Pi released/min/mg protein and expressed 
as percentage of controls.[29]
Statistical analysis
Statistical analysis was performed using the software statisti‑
cal package SPSS 12 (SPSS, Chicago, IL, USA). A univariate 
analysis of variance was performed using genotype (wild‑type 
and transgenic), treatment (transgenic + pomegranate), and their 
interactions as between‑individuals fixed factors. According to 
this, differences between treatments and genotype, or differences 
between transgenic and treatment, were analyzed. For pairwise 
comparison, Scheffe  test (as a post‑hoc test) was applied to deter‑
mine the level of significance between groups. Results are given 
as mean values ± standard deviation (SD). For all tests, the level 
of statistical significance was set at P < 0.05.
RESULTS
The effect of 4% pomegranate (石榴 Shí Liú) on LPO and 
protein carbonyls in APPsw (Tg2576) mice
Disease control APPsw (Tg2576) mice showed significant in‑
crease in LPO levels in both brain regions studied (cortex and hip‑
pocampus), as compared to wild control mice [Table 2]. However, 
treatment with 4% pomegranate dietary supplementation in  AP‑
Psw (Tg2576) mice for15 months attenuated LPO levels to values 
comparable to wild control mice. Table 2 depicts significantly 
elevated levels of protein carbonyls in control APPsw (Tg2576) 
mice as compared to wild control mice (cortex and hippocampus). 
Dietary supplementation with 4% pomegranate significantly at‑
tenuated the protein carbonyl levels in APPsw (Tg2576) mice.
Effect of 4% pomegranate on changes in the antioxidant 
enzymes in APPsw (Tg2576) mice
It is evident from the data that there was a significant decrease 
in the activity of SOD in cerebral cortex and hippocampus in AD 
mice when compared to wild control mice [Table 3]. However, 
the SOD activity was significantly elevated by 4% pomegranate 
dietary supplementation in the cerebral cortex and hippocampus 
of APPSw (Tg2576) AD mice. Disease control transgenic mice 
showed significant reduction in CAT activity in the cortex and 
hippocampus. Dietary supplementation with 4% pomegranate 
subsequently enhanced the CAT activity both in the cortex and 
hippocampus [Table 3] in AD mice.
GSH activity of disease control APPsw (Tg2576) mice was 
significantly lower in the cortex and hippocampus as compared 
to wild control mice [Table 4]. However, treatment with 4% 
pomegranate dietary supplementation restored the GSH activity 
to near‑normal levels in the cortex and hippocampus. The data for 
GPx activity are depicted in Table 4. A significant decrease in GPx 
activity in the cortex and hippocampus was observed in disease 
control AD mice. Dietary supplementation with 4% pomegranate 
was found to protect the GPx activity; the activity was increased 
in the cortex and hippocampus, respectively. GR activity was 
significantly reduced in the brain regions, cerebral cortex and hip‑
pocampus, in AD mice. The activity was restored with long‑term 
supplementation of 4% pomegranate [Table 4].
Table 2. Effect of pomegranate on lipid peroxidation and protein 
carbonyl content in the cortex and hippocampus
Groups MDA levels 
(nmol/mg protein)
Protein carbonyl 
(nmol/mg protein)
Cortex Hippocampus Cortex Hippocampus
Control wild type 1.60±0.12a 0.90±0.07a 30.01±0.06a 51.01±0.06a 
Control Tg 3.60±0.28b 2.10±0.16b 81.26±0.05b 132.14±0.05b
Pomegranate Tg 2.40±0.18c 1.20±0.09c 40.53±6.82c 90.26±6.82c
Data are presented as mean±SD, n=6/group. Values not sharing a common 
superscript (a, b, and c) differ significantly at P<0.05 (DMRT)
Table 3. Effect of pomegranate on superoxide dismutase and catalase 
activities in the brain of mice
Groups Superoxide dismutase 
(U/mg protein)
Catalase 
(U/mg protein)
Cortex Hippocampus Cortex Hippocampus
Control wild 196.03±14.93a 215.04±16.37a 3.80±0.29a 4.30±0.33a 
Control Tg 114.06±8.73b 128.06±9.80b 1.70±0.13b 2.20±0.17b
Pomegranate Tg 181.03±13.78c 196.03±14.93c 3.40±0.26c 3.90±0.30c
Data are presented as mean±SD, n=6/group. Values not sharing a common 
superscript (a, b, and c) differ significantly at P<0.05 (DMRT)
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The effect of 4% pomegranate on alterations in 
membrane‑bound enzymes in AD transgenic mice
AChE activity significantly increased in the cortex and hippo‑
campus of AD mice and 4% pomegranate dietary supplementation 
for 15 months attenuated AChE activity in the cerebral cortex and 
hippocampus. Disease control APPsw (Tg2576) mice showed 
significantly inhibited activity of Na+ K+‑ATPase in the cortex 
and hippocampus. In 4% pomegranate dietary supplemented 
mice, there was a significant improvement in the activities of 
membrane‑bound enzymes [Table 5].
DISCUSSION
Studies demonstrate that the beneficial action of pomegran‑
ate (石榴 Shí Liú) is mediated through attenuation  of oxidative 
stress in  APPSw (Tg2576) mice. The present study suggests that 
the anti‑AD–like effects of pomegranate grown in Oman might 
be related to its high antioxidant activities.[30‑32] ROS can damage 
essential cellular constituents such as lipids and proteins, which 
can be measured by identification of their byproducts malondial‑
dehyde and protein carbonyl, respectively.[33] We observed increase 
in MDA production and protein carbonylation in the cerebral 
cortex and hippocampus of AD mice, indicating that oxidative 
stress occurs as a consequence of AD, thereby contributing to 
brain damage. Dietary supplementation of pomegranate notably 
inhibited the accumulation of MDA and protein carbonyl levels 
in the cortex and hippocampus of Tg2576 mice, which is an oxi‑
dized byproduct of  LPO. In this context, pomegranate has been 
demonstrated to have direct antioxidant effects,[34,35] and decreased 
MDA and protein carbonyl content were demonstrated after daily 
administration of pomegranate juice.[35,36]
GSH is the primary defense in neurons against oxidative stress 
and maintains cellular redox homeostasis.[37] In our experiment, 
we observed a significant decrease in the GSH levels in the brain 
of Tg2576 disease control mice as compared to wild controls. It 
is known that GSH depletion is the first indicator of oxidative 
stress during neurodegenerative diseases.[38] Pomegranate supple‑
mentation to AD mice was able to reverse the decreased GSH 
levels. Ajaikumar et al.[39] reported the reversal in GSH levels in 
aspirin‑ and ethanol‑induced gastric ulceration following pome‑
granate administration, suggesting the efficacy of pomegranate in 
preventing the oxidative damage and associated changes.
SOD is responsible for catalyzing the conversion of superoxide 
anions into hydrogen peroxide[40] which is further decomposed into 
water and oxygen by CAT.[41] The activities of SOD and CAT were 
found to be significantly diminished in the cortex and hippocam‑
pus of Tg2576 disease control mice. Dietary supplementation of 
pomegranate to Tg2576 AD mice prevented the reduction in the 
activities of SOD and CAT. Studies have shown that pomegranate 
could directly inhibit the superoxide anion formation which could 
activation of SOD and CAT. This result suggests that the neuro‑
protective effects of pomegranate might be due to its antioxidant 
activity.[34‑36,39,42]
GPx and GR represent a crucial defensive system to protect 
cells against ROS.[43] The activities of GPx and GR were signifi‑
cantly decreased in the brain regions of AD mice, and a significant 
decrease in the activities of these enzymes during experimental 
dementia was reported.[44] On the other hand, Fan et al.[45] have 
reported decreased GPx and GR activities as a result of oxidative 
stress in scopolamine‑induced amnesia in the hippocampus and 
cerebral cortex. Pomegranate supplementation significantly at‑
tenuated the elevated levels of GPx and GR in the brain regions. 
Pomegranate has been shown to be successful in increasing the 
activities of GPx and GR enzymes in animals with aspirin‑ and 
ethanol‑induced gastric ulceration[39] and improving the antioxi‑
dant function in elderly subjects.[36] The mechanism involved in 
restoration of the activities of these enzymes by pomegranate 
might include prevention of critical –SH group of these enzymes 
that is involved in catalysis.
AChE is an acetylcholine hydrolyzing enzyme that is respon‑
sible for the termination of cholinergic response.[46] The AChE 
activity was found to be markedly elevated in the brain regions 
of Tg2576 AD mice. This observation collaborates with previous 
reports whereby Intracerebrobentricular (i.c.v.) administration of 
streptozotocin at sub‑diabetogenic dose has been shown to induce 
memory deficits, along with an increase in oxidative stress and AChE 
activity.[47] Koladiya et al.[48] have reported that AChE activity was 
significantly increased in the hippocampus in L‑methionine–induced 
model of vascular dementia. The activity of AChE depends largely 
on the membrane characteristics, since the enzyme is membrane 
bound. Amyloid beta peptides can induce Ca2+ influx that leads to 
increased activity of AChE which is attributed to Ca2+‑mediated 
oxidative stress.[49] In our study, long‑term pomegranate supple‑
mentation thorugh diet was found to inhibit AChE activity. Previous 
studies supporting the leaf extracts of pomegranate were obtained 
for the AChE inhibitory activity and antioxidant effects.[50] The 
mechanism of anticholinesterase activity of pomegranate appears 
to be complicated and needs further investigation.
Modification in Na+ K+‑ATPase activity may induce neuronal 
death with features of both apoptosis and necrosis.[51] In the current 
study, the activity of Na+ K+‑ATPase was found to be decreased in 
Tg2576 AD mice, which is in line with the other studies report‑
Table 4. Protective effect of pomegranate dietary supplementation on glutathione‑dependent antioxidant enzymes
Groups Glutathione peroxidase (nmol NADPH 
oxidized/min/mg protein)
GSH 
(mg/g protein)
Glutathione reductase (nmol NADPH 
oxidized/min/mg protein)
Cortex Hippocampus Cortex Hippocampus Cortex Hippocampus
Control wild 12.00±0.91a 24.00±1.83a 4.20±0.32a 5.80±0.44a 11.00±0.84a 11.70±0.89a
Control Tg 5.00±0.38b 11.01±0.84b 2.10±0.16b 3.20±0.25b 4.00±0.31b 4.60±0.35b
Pomegranate Tg 10.40±0.79c 19.80±1.51c 3.70±0.28c 5.20±0.40c 9.30±0.71c 10.10±0.77c
Data are presented as mean±SD, n=6/group. Values not sharing a common superscript (a, b, and c) differ significantly at P<0.05 DMRT: Duncan’s multiple 
range test, NADPH: Nicotinamide adenine dinucleotide phosphate
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ing reduced enzyme activity during aging.[52,53] Na+ K+‑ATPase 
is known to be highly susceptible to changes in the membrane 
lipids, which may be further attributed to the progressive in‑
crease in the LPO.[54,55] ROS overproduction inhibits the activity 
of ATPase via thiol‑ and lipid‑dependent mechanisms.[56] It has 
been demonstrated that the reduced activity of Na+ K+‑ATPase 
caused by oxidative stress cannot drive the ion pumps to maintain 
depolarization of neurons and, thus, may become lethal to neu‑
rons.[57] The mechanism of action of pomegranate in improving 
Na+ K+‑ATPase activity is uncertain, as its multiple active com‑
pounds such as anthocyanins, ascorbic acid, ellagic acid, gallic 
acid, fumaric acid, caffeic acid, catechin, Epigallocatechingallate 
(EGCG), quercetin, rutin, tannins, alkaloids, and flavanoids have 
multiple functions, making it pharmacologically complex. How‑
ever, the antioxidant properties of pomegranate have been well 
documented, which include free radical scavenging and inhibition 
of LPO as well as enhancement of antioxidant status[30‑32] and neu‑
roprotection.[17‑19,58] The results of our present study are supported 
by the previous studies on short‑term oral juice supplementation 
in AD mice.[17‑19,58]
We recently reported that chronic dietary term supplementa‑
tion of fruits could be beneficial for behavior and oxidative stress 
related changes in AD transgenic mice[59‑62] which also support 
our present findings.
CONCLUSION
Pomegranates grown in Oman provide possible protection 
against the oxidative stress and have antioxidant effects in Tg2576 
AD mice brain, and the mechanism of protection may be related 
to their antioxidant activity and phenolic constituents. These re‑
sults warrant further exploration of how the anti‑ROS property of 
pomegranate affords such beneficial effects on the AD mice brain. 
This study also supports an important concept that the onset of 
neurodegenerative disease may be delayed or mitigated by the use 
of dietary preventive agents that protect against AD by reducing 
the oxidative stress.
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